FDA
approval
· 2021-06-04
FDA Approved: TEMBEXA — Original Application (Emergent BioDefense Operations Lansing LLC)
Summary
FDA approved TEMBEXA (brincidofovir) under the original NDA (NDA214460) for the treatment of smallpox (Variola virus), developed by Emergent BioDefense Operatio…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for TEMBEXA (BRINCIDOFOVIR)